A DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THEEFFICACY AND TOLERABILITY OF ANTI-POLLUTION PRODUCT (S) ON FACIAL SKIN OF HEALTHY HUMAN SUBJECTS OVER A PERIOD OF TWO WEEKS

ITC Limited ITC Life Sciences Technology Centre0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Healthy male and female subjects aged 18-50 years old (both inclusive)
•2. Occupationally be exposed to an excessively high concentration of air pollution (i.e.
•outdoor workers)
•3. Having sensitive skin or normal skin (as evaluated by stinging test)
•4. Have lived in this high air pollution area for at least the past 2 years OR they must have
•been occupationally exposed to this high air pollution for the past 2 years
•5. Not be using fairness or antiaging or sunscreen creams/lotions
•6. Free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face
•7. Agree not to use any other product/treatment (eg: night cream) on their face during the
•study period (for male subjects shaving cream/foam/gel can be used for shaving purpose)
•8. Agree not to carry out bleaching or any other procedures including facial etc. on face
•during the study period
•9. Agree to remove all jewellery on/around face (e.g., necklace, earrings, nose ring) during
•VISIA imaging
•10. Female subjects with child-bearing potential willing to undergo Urine Pregnancy Test on baseline visit and to use acceptable methods of contraception
•11. Subject willing to provide written informed consent and is able to read, speak, write, and
•understand English or Hindi
•12. Ready to follow instructions and study restrictions during the study period

•1. Known hypersensitivity to any of the study products or constituents
•2. Any significant skin pathology in the test area
•3. Currently taking any medication including food supplements, which the Investigator
•believes may influence the interpretation of the data
•4. Having chronic illness or had major surgery in the last year
•5. Undergoing any treatment of any skin condition on their face/body
•6. Allergic or sensitive to bar cleansing products, creams/lotions, artificial jewellery or anything else
•7. Females in pregnancy (self-declared on screening visit and confirmed by UPT on baseline visit) or lactation at the beginning of the study or planned during the study
•8. Participation in any other clinical trial up to 1 month prior to inclusion and during the
•9. Any topical or systemic treatment(s) such as NSAIDs, corticosteroids, retinoids, vitamins
•etc. that, in the investigatorÃ¢â?¬•s judgement, could interfere with the study treatments /
•assessments, taken 2 weeks prior to inclusion and / or planned during the study
•10. Who have started, stopped or changed their hormonal treatment(s) (including contraceptive pill) in the previous one month prior to the study
•11. Any history of allergy to NSAIDs, vitiligo, herpes, local infection & epilepsy

发起方

ITC Limited ITC Life Sciences Technology Centre